Seismic Pharma

Seismic Therapeutic is a biotechnology company dedicated to discovering and developing the next generation of biologics for the treatment of autoimmune diseases. The company leverages its proprietary IMPACT platform, which integrates machine learning with structural biology, protein engineering, and translational immunology to accelerate the drug discovery process. Seismic's pipeline features novel therapeutic candidates, including IgG-cleaving enzymes and dual-cell bidirectional antibodies designed to precisely modulate the immune system. By optimizing protein sequences for both therapeutic function and reduced immunogenicity, the company aims to provide superior treatments for patients with chronic immunological conditions. Seismic is backed by a strong syndicate of life science investors and led by a team of experienced industry veterans.